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ABSTRACT :  Three different NP antigenic sites were identified using deleted truncated 
NP mutants purified from Escherichia coli. One of the antigenic sites was located within 
amino acids 441 to 489 of C-terminal. Two other antigenic sites located within the N-
terminal of NP protein from amino acids 26 to 121 and 122 to 375 residues. Identification 
of NP antigenic sites not only elucidates the NP sequences that are responsible in eliciting 
immune response, indirectly it also revealed which sequences are exposed on the NP 
herringbone-like structure. 
Keywords:   Monoclonal antibody; nucleocapsid; antigenic sites; Newcastle disease virus 
1. INTRODUCTION  
 Nucleocapsid (NP) protein is the major component of Newcastle disease virus 
(NDV). Under electron microscopy, it resembles herringbone morphology with spikes 
protruding from a central channel which is in common with other members of 
Paramyxoviridae familiy. Trypsin digestion of NP does not disrupt the structure of the NP, 
but does release a 12 K molecular weight fragment [1].  
It plays a critical role in the replication of the virus in the host cells. Together with 
the viral genome, it forms a NP-genome complex which acts as a template for genome 
synthesis and transcription. This complex binds to phosphoprotein-L protein (P-L) 
complex which acts as a polymerase to synthesize RNA genome [2]. The switch between 
replication and transcription by these complexes however are still not fully solved yet. 
During virus assembly, the NP is most likely to interact with the M protein [3]. Binding of 
the M protein to NP protein would mediate the interaction between the NP and the viral 
lipid membrane which results in the budding and release of virus progenies from the cell 
plasma membrane [4,5]. 
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NP is composed of 489 amino acids with a predicted molecular weight of 53 kDa 
and is encoded by a 1470 bp NP gene [6]. Based on the amino acid sequence analysis, the 
NP of NDV shares a high degree of homology (91-98%) with those of the other strains of 
NDV. The N-terminal region of the NP up to residue 401 is highly conserved among NDV 
strains and variability among the NPs has been detected within the C-terminal portion 
similar to what has been reported for other members of the Paramyxovirinae [7]. 
However, recent study has shown that two regions from residues 444 to 459 and the final 8 
amino acids of C-terminal of NP are conserved [8]. The NP of NDV was shown to be 
moderately homologous (30-40%) among the other members of the Rubulavirus [6]. In 
comparison with the other two genera within the Paramyxovirinae subfamily, 
Paramyxovirus and Morbillivirus, the NP protein of NDV  shares  27%  homology  and  
the  length  varies  from  489  to  551  amino  acid residues with the predicted molecular 
weight of 53-56 kDa.  The central segment of the NP protein among 27 strains in the 
Paramyxoviridae remained conserved compared to the other regions of NP protein [6].  
The NP was successfully self-assembled to form herringbone-like particles that 
closely resembled those isolated from intact virions when expressed in baculovirus [9] and 
E. coli [10].  Similar observations were reported for the NP protein of Sendai and measles 
viruses [11,12]. However, apart from herringbone-like particles, ring-like particles were 
also observed in the expression of NP in E. coli [10]. Western blot analysis showed that 
the expressed NP was indistinguishable immunologically from virion-derived NP [13]. 
  To date, mAbs against NP of NDV have been produced in several laboratories 
around the world [14, 15, 16, 17]. Most of them used the antibodies for detecting antigenic 
diversity and similarities among NDV strains [18, 16, 19]. One study however, managed 
to delineate the antigenic sites recognized by the antibodies [20]. Unfortunately the exact 
locations of the antigenic sites were not determined. Therefore the present study was 
carried out to identify its antigenic sites by using Western blotting. 
2. MATERIALS AND METHODS 
2.1 Full length and truncated NP construct  
Full length and four truncated NP genes used were as described in Kho et al. (2001a) 
[6] and Kho et al. (2003) [21]. The coding sequences were cloned in pTrcHis2 (Invitrogen, 
USA) and transformed into Escherichia coli strain TOP10 (Invitrogen, USA). The 
expression of the genes produced full length NP, two C-terminally truncated NP (NP1-440 
and NP1-375) and two N-terminally truncated NP (NP26-489 and NP122-489) mutants as shown 
in Figure 1.  
2.2 Purification of full length and truncated NP proteins 
 The purification of the full length and deleted NP mutants from E. coli were described 
previously by Kho et al. (2001b) [10] and were performed with slight modifications. 
Bacterial cultures 250 ml were grown at 37
o
C in LB broth until the culture reached A600 
around 0.6 to 0.8. After induction with 1 mM IPTG for 5 h, the cells were harvested by 
centrifugation at 10,000 xg for 10 min at 4
o
C. The pellets were lysed in lysis buffer [50mM 
Tris (pH 7.9), 0.1% Triton X-100, 0.2 mg/ml lysozyme, 4 mM MgCl2], treated with 5 
µg/ml RNase and 5 µg/ml RNase DNase (Amresco, USA) for 30 min at room temperature 
and followed by sonication (30 s) at high frequency for five times. The cell extracts were 
recovered by centrifugation at 20,000 xg for 20 min at 4
o
C and precipitated by ammonium 
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sulphate (0 to 60% saturation). The precipitates were pelleted by centrifugation under the 
same conditions and dialyzed extensively in dialysis buffer (50 mM Tris, 100 mM NaCl, 
pH 7.8). The dialyzed solutions were carefully layered to 10-50% sucrose gradient and 
centrifuged at 110,000 xg for 5 h at 4
o
C. Fractions containing the full length NP were 
pooled, dialyzed and then concentrated with a 100 kDa cut-off Centricon centrifugal filter 
(Milipore, USA) for immunization purpose. While fractions containing NP deleted 
mutants were kept at 4
o
C. 
 
Figure 1: Schematic representation of the deletion mutants of NP. Thick lines represent the 
protein product of each truncated NP gene and the amino acid positions are indicated on 
top of theses lines. Angled lines indicate deleted regions. 
2.3 SDS-PAGE and Western Blot 
Purified NDV or NP proteins were separated by sodium dodecyl  sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) according to Laemmli (1970) [21]. After 
the electrophoresis, the fractionated proteins were blotted onto a nitrocellulose membrane 
(Osmonics, USA) and Western blotting was performed according to Harlow and Lane 
(1988) [23] with some modifications. The blotted membranes were incubated in culture 
fluids of mAbs instead of diluted serum before incubation with secondary antibody 
conjugated to alkaline phosphatase. Nitro-blue tetrazolium chloride (NBT; Amresco, 
USA) and bromochloroindolyl phosphate (BCIP; Amresco, USA) were used as a substrate 
solution. Polyclonal antiserum against NDV or NP was used as a positive control.  
2.4 Software Analysis 
Amino acid sequence of NP of NDV strain AF2240 was analyzed using the antigenic 
index (Kolaskar and Tongaonkar method) [24] and hydrophobicity plot (Kyte-Doolittles 
method) [25] for prediction of antigenic sites. Higher peak in antigenic index means 
higher probability of the sequence to be antigenic.  For hydrophobicity plot, peak with 
positive value indicates hydrophobic sequence and the negative value, hydrophilic. 
3. RESULTS AND DISCUSSION  
3.1 Full length and truncated NP proteins 
In this method, two C-terminally truncated NP (NP1-440 and NP1-375) and two N-
terminally truncated NP (NP26-489 and NP122-489) mutants were used (Figure 1). The 
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recombinants of full length and truncated NP constructs produced by Kho et al. [6, 28] 
were checked for their truncated NP genes by PCR before the respected proteins were 
purified. Both the full length and deleted NP mutants were purified using ammonium 
sulphate precipitation and sucrose gradient ultracentrifugation and the purified full length 
and NP mutants obtained were similar as Kho et al. [28] (data not shown). 
3.2 NP antigenic sites 
For localization of NP antigenic sites, purified deleted NP mutants were used. The 
purified full length and truncated NP proteins were analysed with SDS-PAGE, transferred 
to a nitrocellulose membrane and probed with all of the mAbs culture fluids and 
polyclonal NP mouse serum separately. The polyclonal antibody which served as a 
positive control, bound to all linearized NP mutants indicating that some of the epitopes in 
all of the mutants were not conformational (Figure 3a). MAbs a2, a2s and b2 recognized 
only those NP mutants containing only the C-terminal end (Figure 3b). Deletion of 49 
amino acid residues from the C-terminal end of NP totally abolished the binding of these 
antibodies with the mutants (NP1-440) indicating that the NP antigenic sites are located 
between, amino acids 441 to 489. MAbs b3 and b4s reacted with all of the C- truncated 
mutants but not with all of the N-truncated mutants suggesting that the antigenic sites were 
located in the N-terminal portion (Figure 3b). Deletion of 25 amino acids (NP26-489) from 
the N-terminal end did not affect the binding of both antibodies, however further deletion 
of 121 amino acids (NP122-489) abolished the binding. This shows that the antigenic sites 
recognized by mAbs b3 and b4s are located within amino acids 26 to 121. On the other 
hand, mAb c1 bound to all of the C- and N-truncated mutants suggesting that all the 
deleted amino acid sequences are not part of the epitope for this antibody (Figure 3c). This 
indicates that antigenic sites may be located from amino acids 122 to 375. 
In previous study, Panshin et al. (2000) [25] has delineated at least three antigenic sites 
on the NP using nine NP mAbs by a competitive binding assay. However, the exact 
locations of these have yet to be mapped. In this study, by using deleted NP mutants 
purified from E. coli to locate the NP antigenic sites, three different antigenic sites were 
recognized by six mAbs, one at the C-terminal of NP and two at the N-terminal of NP. 
The antigenic site at the C-terminus of NP which was recognized by mAbs a2, a2s and 
b2 was localized within amino acids 441 to 489. Based on the amino acid sequence 
analysis of NP of NDV, this antigenic site was located within the highly variable region of 
NP [7]. In contrast, cross-reactivity analysis showed that the epitopes of these mAbs 
appear to be within the conserved sequence of NP. It seems that the antigenic site 
determined by the Western blot analysis was not in parallel with the cross-reactivity 
analysis. Nevertheless, recent amino acid sequence analysis on Japanese isolates revealed 
that there were two smaller regions within the NP variable region (444 to 459 residues and 
the final 8 amino acids of the C-terminal) are well conserved among the strains [8]. 
Perhaps, the epitopes recognized by these mAbs may be localized within these two 
conserved sequences instead of the variable sequences within the amino acids 441 to 489 
region. Interestingly, antigenic software analysis showed that amino acids 446-452 which 
overlapped with one of this NP conserved region is antigenic (Figure 4, *3*). Although 
the region seemed to be quite hydrophobic (Figure 5), the B-cell immunodominant epitope 
of NP of NDV was apparently also located on this site from 447 to 455 [29]. It is therefore 
possible that the exact epitopes of these three mAbs might be located within residues 446 
to 455. However, further studies using synthetic peptides covering this region are required 
to verify the locations. 
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 Unlike the antigenic NP sites of Sendai virus which are restricted to the C-terminal of 
NP protein [26], our study shows that the antigenic regions of NDV NP are also located at 
the N-terminal of the NP protein. Two non-overlapping antigenic sites of NDV NP were 
located from residues 26 to 121 (identified by mAbs b3 and b4s) and from residues 122 to 
375 (bound by mAbs c1) of the N-terminal of NP protein. .  Interestingly, these two 
antigenic sites determined by the Western blotting were overlapped with  the amino acid 
sequences which are predicted to be the most probable epitopes (amino acids 68 to 81 and 
199 to 234; Figure 4, *1* and *2*) by antigenic software analysis. However, further 
investigations to narrow down these two antigenic sites are required in the future so that a 
better understanding of antigenic structures of NDV NP could be obtained. 
Figure 3: Western blot analysis of the truncated NP. 
Purified full-length of NP and truncated NP mutants were fractionated on SDS-PAGE, 
electrotransferred to nitrocellulose membrane and probed with polyclonal NP serum and 
each of six mAbs. Lane 1 represents full-length NP and lanes 2 to 5 represent both N- and 
C-terminally truncated NP122-489, NP26-489, NP1-375 and NP1-440. M, protein molecular 
weight marker. (a) The results obtained with polyclonal NP mouse serum; (b) The results 
obtained with mAbs b2, an identical pattern was observed with mAbs a2 and a2s   (c) The 
results obtained with mAbs b4s, an identical pattern was observed with mAbs b3, (d) The 
results obtained with mAbs c1.  
 
In general, antigenic sites would normally be located on the exposed surface of a 
protein molecule [27]. Thus, the findings of this study were partly in agreement with the 
observation made by Kho et al. [10] when one of the antigenic sites was localized within 
the C-terminal end of NP.  Kho et al. [10] observed that the peptide fused to the C-
terminal end of NP of NDV was located on the surface of NP structure under the electron 
microscopy indicating that the C-terminus of NP was exposed on the surface of NP 
structure. Interestingly, the present study also located two antigenic sites located within 
the internal region of N-terminal of the NP suggesting that some of the amino acid 
sequences within this region were probably exposed on the surface of NP. In contrast, Kho 
et al. [28] demonstrates that a large part of the N-terminal encompassing amino acids 1 to 
375 were required for proper folding to form NP herringbone-like structure which implies 
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that those amino acids are probably buried inside the NP structure. It is quite difficult to 
explain this discrepancy unless there are probably small regions within the amino acids 1 
to 375 which are exposed on the surface of NP for antibodies to bind. Further studies on 
the NP herringbone-like structure will probably better explain this assumption. Ultimately, 
this data is essential towards illustrating the NP herringbone-like structure. 
 
Figure 4: Antigenic peptides software analysis of NP (according to the method of Kolaskar 
and Tongaonkar, 1990 [23]). 
There are 20 antigenic determinants predicted by the software. *1* and *2* are sequences 
at positions 68-81 and 199-234 amino acids (N-terminal of NP), respectively which have 
high antigenic propensity value. Antigenic determinants at the C-terminal (*3*; 446-452 
amino acids) of NP have low antigenic propensity value. 
 
Figure 5: Hydrophobic sequence software analysis of NP (according to the method of Kyte 
and Doolittle, 1982 [24]). 
*, Predicted antigenic site at the C-terminal position 446-452 amino acids is quite 
hydrophobic. 
4. CONCLUSIONS  
In this study, three different NP antigenic sites were localized by a panel of mAbs, one 
at the C-terminal of NP and two at the N-terminal of NP. To be exact, the antigenic site at 
the C-terminal was located within amino acids 441 to 489 of C-terminal and the other two 
antigenic sites at the N-terminal of NP protein were located within amino acids 26 to 121 
and 122 to 375 residues. 
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